Creation of a Cohort for the Quantitation and Characterization of Circulating Viral RNAs as a New Biomarker of Hepatitis B Functional Cure.

ConditionHepatitis B
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHospices Civils de Lyon

About this trial

The " CirB-RNA " cohort aims to create a biological collection associated with clinical and biological data from patients with hepatitis B infection. This project is part of a much larger program that aims to characterize and quantify circulating viral RNAs as a possible new biomarker of hepatitis B functional cure.

Eligibility criteria

Qualifiers

Adults patients and minor children over 6 years of age (in Lyon) with acute or chronic hepatitis B or presenting with HBsAg loss (with/without HBs seroconversion). (Co-infected patients with HDV and/or HCV and/or HIV are eligible)

Patients requiring blood sampling for medical care at the time of the medical appointment.

Informed patients who do not refuse to participate.

Persons not affiliated to a social security scheme and persons receiving medical assistance from the state may be asked to participate in the study

Disqualifiers

Patients participating at the time of the inclusion to an interventional trial evaluating a drug likely to interfere with this study.

Persons deprived of their liberty by a judicial or administrative decision

Adults who are subject to a legal protection measure

Children less than 6 years old (in Lyon)

Trial design

Treatments tested in this trial

  • Blood sampling

Treatment groups

No treatment groups listed

Sponsors and collaborators